France-based pharmaceutical major Sanofi has acquired the rights to an investigational acne treatment, signalling a move into the lucrative market.
The company’s Sanofi Pasteur unit has signed a collaboration agreement with the University of California, San Diego, US, to focus on acne prevention through an immunological approach.
Sanofi estimates that the worldwide market for acne treatments could be worth in excess of $3bn per year, with more than 50 million people suffering from acne in the US alone.
Financial terms of the agreement have not been disclosed.
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.
Excellence in Action Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.
